ChiKeon Loh - IHH Healthcare Executive Director
| IHHHFDelisted Stock | USD 1.19 0.00 0.00% |
Director
Dr. Loh ChiKeon is appointed as Executive Director of the Company, effective July 1, 2019. He joins IHH Healthcare Berhad from Columbia Asia Group where he was Chief Executive Officer . Dr Kelvin Loh started his career as a practicing physician before serving for 10 years in the public sector in Singapore, in areas such as clinical services development, hospital planning and hospital operations. Dr Kelvin Loh previously joined the IHH Group in 2008, and between 2008 and 2017 held a number of senior management roles, before taking over as CEO for the Singapore Operations Division, covering among other services, the 4 multispecialty tertiary hospitals Mount Elizabeth, Mount Elizabeth Novena, Gleneagles and Parkway East. Dr Kelvin Loh moved to Columbia Asia Group as CEO in 2017 where he was responsible for overseeing Columbia Asia Group 28 hospitals across 4 countries in Asia including Malaysia and India. Dr Kelvin Loh is a senior healthcare executive with strong track record of delivery. He has extensive experience in leading large healthcare businesses, building relationships with stakeholders, managing hospital operations, financial management and developing people. He is also deeply familiar with the healthcare operating context in diverse countries across Asia. since 2019.
| Age | 49 |
| Tenure | 5 years |
| Professional Marks | Ph.D |
| Phone | 60 3 2298 9898 |
| Web | https://www.ihhhealthcare.com |
IHH Healthcare Management Efficiency
The company has return on total asset (ROA) of 0.0398 % which means that it generated a profit of $0.0398 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0754 %, meaning that it generated $0.0754 on every $100 dollars invested by stockholders. IHH Healthcare's management efficiency ratios could be used to measure how well IHH Healthcare manages its routine affairs as well as how well it operates its assets and liabilities.IHH Healthcare Berhad has accumulated 7.61 B in total debt with debt to equity ratio (D/E) of 0.32, which is about average as compared to similar companies. IHH Healthcare Berhad has a current ratio of 1.34, which is within standard range for the sector. Debt can assist IHH Healthcare until it has trouble settling it off, either with new capital or with free cash flow. So, IHH Healthcare's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like IHH Healthcare Berhad sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for IHH to invest in growth at high rates of return. When we think about IHH Healthcare's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Tsutomu Yonemoto | Chiba Bank Ltd | 59 | |
| John Switzer | Barings BDC | 63 | |
| Jeffrey Joerres | Artisan Partners Asset | 61 | |
| Matthew Barger | Artisan Partners Asset | 62 | |
| Candace Duncan | Teleflex Incorporated | 67 | |
| Andrew Krakauer | Teleflex Incorporated | 66 | |
| Stephen Klasko | Teleflex Incorporated | 67 | |
| John Heinmiller | Teleflex Incorporated | 66 | |
| Tadayoshi Shinozaki | Chiba Bank Ltd | 58 | |
| Norio Takatsu | Chiba Bank Ltd | 61 | |
| Chigusa Saito | Chiba Bank Ltd | N/A | |
| Arihiko Totsuka | Chiba Bank Ltd | N/A | |
| Richard Packer | Teleflex Incorporated | 62 | |
| Thomas Okel | Barings BDC | 57 | |
| Tench Coxe | Artisan Partners Asset | 62 | |
| Robert Knapp | Barings BDC | 55 | |
| Mark Mulhern | Barings BDC | 60 | |
| Stuart Randle | Teleflex Incorporated | 61 | |
| Jennifer Barbetta | Artisan Partners Asset | 47 | |
| Jill Olmstead | Barings BDC | 56 | |
| Stephanie DiMarco | Artisan Partners Asset | 62 | |
Management Performance
| Return On Equity | 0.0754 | |||
| Return On Asset | 0.0398 |
IHH Healthcare Berhad Leadership Team
Elected by the shareholders, the IHH Healthcare's board of directors comprises two types of representatives: IHH Healthcare inside directors who are chosen from within the company, and outside directors, selected externally and held independent of IHH. The board's role is to monitor IHH Healthcare's management team and ensure that shareholders' interests are well served. IHH Healthcare's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, IHH Healthcare's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Pr Sim, Group Officer | ||
| Ida Rahim, Joint Secretary | ||
| Penelope Koh, Senior Manager - Investor Relations | ||
| Angela Ryan, Group Officer | ||
| Nili Saat, Group Management | ||
| ChiKeon Loh, Executive Director | ||
| Stephen Byrne, Group Audit | ||
| Joerg Ayrle, Chief Officer | ||
| Dilip Kadambi, Group Transformation | ||
| Ashok Pandit, Group Officer |
IHH Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is IHH Healthcare a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0754 | |||
| Return On Asset | 0.0398 | |||
| Profit Margin | 0.10 % | |||
| Operating Margin | 0.17 % | |||
| Current Valuation | 13.54 B | |||
| Shares Outstanding | 8.81 B | |||
| Shares Owned By Insiders | 51.78 % | |||
| Shares Owned By Institutions | 40.52 % | |||
| Price To Earning | 224.08 X | |||
| Price To Book | 1.92 X |
Currently Active Assets on Macroaxis
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Other Consideration for investing in IHH Pink Sheet
If you are still planning to invest in IHH Healthcare Berhad check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the IHH Healthcare's history and understand the potential risks before investing.
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |